beta

ACST

Acasti Pharma Inc.

Acst

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

11-14-2018 08-14-2018 02-13-2018 11-13-2017 08-14-2017 07-11-2016
Actual EPS -0.2 -0.18 -0.31 -0.25 -0.14 -0.23
Consensus EPS -0.21 -0.31
Estimated EPS -0.21 -0.31
Number of Estimates 1 1
EPS Surprise $0.01

Stats

Summary

Acasti Pharma Inc is a biopharmaceutical company. The Company is engaged in the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of cardiometabolic disorders.

Market Cap: 28.3 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.acastipharma.com

Shares Outstanding: 24.8 Million

Float: 24.8 Million

Dividend: 0.0 (0.0%)

Beta: 1.664063

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 48.7 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1347 trading days

From: 2013-08-05 To: 2018-12-14

Lowest Point:

Acasti Pharma's (ACST) CEO Jan D'Alvise on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-14 16:34:10:000

Acasti Pharma, Inc. (ACST) Q2 2018 Earnings Conference Call November 14, 2018, 11:00 ET Executives David Waldman - IR Jan D'Alvise - President and CEO Pierre Lemieux - Chief Operating Officer, Chief Scientific Officer and Co-Founder Brian Groach - Chief Commercial Officer Jea… read more...

Acasti Pharma's (ACST) CEO Jan D'Alvise on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-14 16:34:10:000

Acasti Pharma, Inc. (ACST) Q2 2018 Earnings Conference Call November 14, 2018, 11:00 ET Executives David Waldman - IR Jan D'Alvise - President and CEO Pierre Lemieux - Chief Operating Officer, Chief Scientific Officer and Co-Founder Brian Groach - Chief Commercial Officer Jea… read more...

Acasti Pharma's (ACST) CEO Jan D'Alvise on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-14 16:34:10:000

Acasti Pharma, Inc. (ACST) Q2 2018 Earnings Conference Call November 14, 2018, 11:00 ET Executives David Waldman - IR Jan D'Alvise - President and CEO Pierre Lemieux - Chief Operating Officer, Chief Scientific Officer and Co-Founder Brian Groach - Chief Commercial Officer Jea… read more...

Acasti Pharma closes $19.1M common stock offering

via: SeekingAlpha at 2018-10-11 07:54:41:000

Acasti Pharma (NASDAQ: ACST ) closes its previous public offering of 16.6M common shares in the U.S.at a price of $1.00 per share. More news on: Acasti Pharma, Inc., Healthcare stocks news, Read more … read more...

Acasti Pharma closes $19.1M common stock offering

via: SeekingAlpha at 2018-10-11 07:54:41:000

Acasti Pharma (NASDAQ: ACST ) closes its previous public offering of 16.6M common shares in the U.S.at a price of $1.00 per share. More news on: Acasti Pharma, Inc., Healthcare stocks news, Read more … read more...

Acasti Pharma closes $19.1M common stock offering

via: SeekingAlpha at 2018-10-11 07:54:41:000

Acasti Pharma (NASDAQ: ACST ) closes its previous public offering of 16.6M common shares in the U.S.at a price of $1.00 per share. More news on: Acasti Pharma, Inc., Healthcare stocks news, Read more … read more...

Acasti Pharma prices $16.6M common stock offering

via: SeekingAlpha at 2018-10-05 02:08:30:000

Acasti Pharma (NASDAQ: ACST ) prices its public offering of 16.6M common shares in U.S. at a price of $1.00 per share, for gross proceeds of ~$16.6M. More news on: Acasti Pharma, Inc., Healthcare stocks news, Read more … read more...

Acasti Pharma prices $16.6M common stock offering

via: SeekingAlpha at 2018-10-05 02:08:30:000

Acasti Pharma (NASDAQ: ACST ) prices its public offering of 16.6M common shares in U.S. at a price of $1.00 per share, for gross proceeds of ~$16.6M. More news on: Acasti Pharma, Inc., Healthcare stocks news, Read more … read more...

Acasti Pharma prices $16.6M common stock offering

via: SeekingAlpha at 2018-10-05 02:08:30:000

Acasti Pharma (NASDAQ: ACST ) prices its public offering of 16.6M common shares in U.S. at a price of $1.00 per share, for gross proceeds of ~$16.6M. More news on: Acasti Pharma, Inc., Healthcare stocks news, Read more … read more...

Acasti Pharma prices $16.6M common stock offering

via: SeekingAlpha at 2018-10-05 02:08:30:000

Acasti Pharma (NASDAQ: ACST ) prices its public offering of 16.6M common shares in U.S. at a price of $1.00 per share, for gross proceeds of ~$16.6M. More news on: Acasti Pharma, Inc., Healthcare stocks news, Read more … read more...

Acasti Pharma prices $16.6M common stock offering

via: SeekingAlpha at 2018-10-05 02:08:30:000

Acasti Pharma (NASDAQ: ACST ) prices its public offering of 16.6M common shares in U.S. at a price of $1.00 per share, for gross proceeds of ~$16.6M. More news on: Acasti Pharma, Inc., Healthcare stocks news, Read more … read more...

Premarket Losers as of 9:05 am (10/4/2018)

via: SeekingAlpha at 2018-10-04 09:18:14:000

OGEN -28% . More news on: Oragenics, Inc., Pain Therapeutics, vTv Therapeutics, Stocks on the move, Top stock market news, , Read more … read more...

Acasti Pharma announces proposed underwritten public offering of common shares

via: SeekingAlpha at 2018-10-03 16:34:02:000

Acasti Pharma ( ACST -12.9% ) intends to offer and sell its common shares in an underwritten public offering in the United States. More news on: Acasti Pharma, Inc., Neptune Technologies & Bioresources Inc, Read more … read more...

Midday Gainers / Losers (10/02/2018)

via: SeekingAlpha at 2018-10-02 12:44:16:000

Gainers: OGEN +92% . DTEA +62% . IGC +58% . TRPX +49% . IMTE +43% . SLS +22% . SYN +20% . FTFT +19% . ATRS +19% . INO +18% . More news on: Oragenics, Inc., DAVIDs TEA, India Globalization Capital, Inc, , Stocks on the move, Top stock market news, R… read more...

Premarket Losers as of 9:05 am (10/2/2018)

via: SeekingAlpha at 2018-10-02 09:09:16:000

ABIO -22% . More news on: ARCA biopharma, Inc., Stitch Fix, Inc., New Age Beverages Corporation, Stocks on the move, Top stock market news, , Read more … read more...

Midday Gainers / Losers (10/01/2018)

via: SeekingAlpha at 2018-10-01 12:40:08:000

Gainers: OGEN +51% . LEVB +37% . NBEV +39% . ARCW +30% . NTGN +27% . IGC +25% . IFMK +24% . ACST +21% . ATLC +21% . ALT +21% . More news on: Oragenics, Inc., Level Brands, Inc., New Age Beverages Corporation, Stocks on the move, , Read more … read more...

Premarket Gainers as of 9:05 am (10/01/2018)

via: SeekingAlpha at 2018-10-01 09:26:27:000

SYN +52% . More news on: Synthetic Biologics, Inc., New Age Beverages Corporation, India Globalization Capital, Inc, Stocks on the move, , Top stock market news, Read more … read more...

Citi sees another 5x upside in Amarin

via: SeekingAlpha at 2018-09-24 11:53:44:000

Amarin (NASDAQ: AMRN ) has skyrocketed more than 200% to $10.15 today after its fish oil capsule showed big benefits in a trial of more than 8K patients with elevated risk of heart issues. More news on: Amarin Corporation PLC, Acasti Pharma, Inc., Healthcare stocks news, Stocks… read more...

Citi sees another 5x upside in Amarin

via: SeekingAlpha at 2018-09-24 11:53:44:000

Amarin (NASDAQ: AMRN ) has skyrocketed more than 200% to $10.15 today after its fish oil capsule showed big benefits in a trial of more than 8K patients with elevated risk of heart issues. More news on: Amarin Corporation PLC, Acasti Pharma, Inc., Healthcare stocks news, Stocks… read more...

Citi sees another 5x upside in Amarin

via: SeekingAlpha at 2018-09-24 11:53:44:000

Amarin (NASDAQ: AMRN ) has skyrocketed more than 200% to $10.15 today after its fish oil capsule showed big benefits in a trial of more than 8K patients with elevated risk of heart issues. More news on: Amarin Corporation PLC, Acasti Pharma, Inc., Healthcare stocks news, Stocks… read more...

Acasti Pharma reports Q1 results

via: SeekingAlpha at 2018-08-14 13:04:29:000

Acasti Pharma (NASDAQ: ACST ): Q1 EPS of -C$0.23 vs. -C$0.19 in Q117 Cash and cash equivalents of C$12.9M Press Release More news on: Acasti Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Acasti Pharma reports Q1 results

via: SeekingAlpha at 2018-08-14 13:04:29:000

Acasti Pharma (NASDAQ: ACST ): Q1 EPS of -C$0.23 vs. -C$0.19 in Q117 Cash and cash equivalents of C$12.9M Press Release More news on: Acasti Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Acasti Pharma reports Q1 results

via: SeekingAlpha at 2018-08-14 13:04:29:000

Acasti Pharma (NASDAQ: ACST ): Q1 EPS of -C$0.23 vs. -C$0.19 in Q117 Cash and cash equivalents of C$12.9M Press Release More news on: Acasti Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Who Is Shorting Cannabis Stocks?

via: SeekingAlpha at 2018-07-08 13:16:59:000

Given the meteoric rise of cannabis stocks in the last couple years, many investors have wondered if there is a large short interest in the cannabis sector. As part of our comprehensive coverage of the cannabis sector, we decided to take a deep dive into this topic and discuss implications for… read more...

Who Is Shorting Cannabis Stocks?

via: SeekingAlpha at 2018-07-08 13:16:59:000

Given the meteoric rise of cannabis stocks in the last couple years, many investors have wondered if there is a large short interest in the cannabis sector. As part of our comprehensive coverage of the cannabis sector, we decided to take a deep dive into this topic and discuss implications for… read more...

Who Is Shorting Cannabis Stocks?

via: SeekingAlpha at 2018-07-08 13:16:59:000

Given the meteoric rise of cannabis stocks in the last couple years, many investors have wondered if there is a large short interest in the cannabis sector. As part of our comprehensive coverage of the cannabis sector, we decided to take a deep dive into this topic and discuss implications for… read more...

Acasti Pharma reports Q4 results

via: SeekingAlpha at 2018-06-27 17:14:43:000

Acasti Pharma (NASDAQ: ACST ): Q4 EPS of -C$0.32 More news on: Acasti Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Acasti Pharma reports Q4 results

via: SeekingAlpha at 2018-06-27 17:14:43:000

Acasti Pharma (NASDAQ: ACST ): Q4 EPS of -C$0.32 More news on: Acasti Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Acasti Pharma reports Q4 results

via: SeekingAlpha at 2018-06-27 17:14:43:000

Acasti Pharma (NASDAQ: ACST ): Q4 EPS of -C$0.32 More news on: Acasti Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Acasti Pharma reports Q3 results

via: SeekingAlpha at 2018-02-13 17:04:58:000

Acasti Pharma (NASDAQ: ACST ): Q3 EPS of -C$0.40 Cash and equivalents of C$12.5M Press Release More news on: Acasti Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Acasti Pharma reports Q3 results

via: SeekingAlpha at 2018-02-13 17:04:58:000

Acasti Pharma (NASDAQ: ACST ): Q3 EPS of -C$0.40 Cash and equivalents of C$12.5M Press Release More news on: Acasti Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Acasti Pharma reports Q3 results

via: SeekingAlpha at 2018-02-13 17:04:58:000

Acasti Pharma (NASDAQ: ACST ): Q3 EPS of -C$0.40 Cash and equivalents of C$12.5M Press Release More news on: Acasti Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Your Daily Pharma Scoop: Ablynx Takeover Bid, Celgene Acquires Impact Biomedicines, Axovant Flops Again

via: SeekingAlpha at 2018-01-09 11:02:20:000

Analysis of top Seeking Alpha coverage: Ablynx Today we will discuss the hostile takeover bid from Novo Nordisk ( NVO ) for clinical-stage Belgian biotech company Ablynx ( OTCPK:ABLYF ). On Monday , Novo made a euro 2.6 billion ($3.1 billion) offer to acquire Ablynx. Novo has offered … read more...

Premarket Gainers as of 9:05 am

via: SeekingAlpha at 2018-01-05 09:21:52:000

CNIT +63% on ad terminal sale . More news on: China Information Technology, ChinaCache International, China Commercial Credit, Stocks on the move, Read more … read more...

Your Daily Pharma Scoop: Intercept Updates On NASH Trial, GW Pharmaceuticals Provides Regulatory Update, Odonate Initiates Trial

via: SeekingAlpha at 2017-12-30 13:35:25:000

Analysis of top Seeking Alpha coverage: Intercept Today we will discuss an update from Intercept Pharmaceuticals ( ICPT ) with regards to its REVERSE trial in NASH patients with compensated cirrhosis. Intercept had earlier guided for commencing the Phase 3 trial by the end of this year… read more...

Acasti Pharma closes US$10M firm commitment offering of common shares and warrants

via: SeekingAlpha at 2017-12-28 07:58:51:000

Acasti Pharma (NASDAQ: ACST ) announces the closing of its firm commitment offering of 9.9M common shares and warrants to purchase an aggregate of 9.8M common shares (including the exercise of the over-allotment option for warrants) at a combined price of US$1.01 per share for the gross pr… read more...

Your Daily Pharma Scoop: Biogen Setback, Ironwood Commences Trial, Vtv Signs 2 Deals

via: SeekingAlpha at 2017-12-23 11:37:46:000

Analysis of top Seeking Alpha coverage: Biogen Today we will focus on Biogens ( BIIB ) announcement regarding BAN2401, the companys Alzheimers candidate in mid-stage study. Biogen shares dropped more than 3% on Thursday after the company said that an Independent D… read more...

Midday Gainers / Losers

via: SeekingAlpha at 2017-12-21 12:47:15:000

Gainers: LTEA +177% . NXTD +120% . AEZS +47% . JTPY +49% . GNRT +30% . NETE +21% . ERJ +23% . SAEX +18% . HSGX +18% . MICT +17% . More news on: Long Island Iced Tea Corp., NXT-ID Inc., AEterna Zentaris, Inc., Stocks on the move, Read more … read more...

Acasti Pharma prices $10M equity offering; shares down 26% premarket

via: SeekingAlpha at 2017-12-21 09:17:49:000

Acsati Pharma (NASDAQ: ACST ) slumps 26% premarket on robust volume in response to its public offering of ~9.9M shares of common stock and accompanying warrants to purchase up to ~8.9M shares of common for $1.01 per share and warrant. More news on: Acasti Pharma, Inc., Health… read more...

Premarket Losers as of 9:05 am

via: SeekingAlpha at 2017-12-21 09:11:16:000

ACST -26% on pricing US$10M offering of common shares and warrants. More news on: Acasti Pharma, Inc., PG&E Corporation, Bed Bath & Beyond Inc., Stocks on the move, Read more … read more...

Premarket Losers as of 9:05 am

via: SeekingAlpha at 2017-12-20 09:11:21:000

ACST -27% on announcing planned public offering. More news on: Acasti Pharma, Inc., ChinaCache International, Stitch Fix, Inc., Stocks on the move, Read more … read more...

Midday Gainers / Losers

via: SeekingAlpha at 2017-11-27 12:43:09:000

Gainers: CERC +45% . MARA +29% . MGCD +24% . SGRP +21% . NOG +20% . GROW +19% . OPHC +18% . UTSI +17% . CUDA +16% . QD +16% . More news on: Cerecor, Marathon Patent Group, Inc., MGC Diagnostics Corporation, Stocks on the move, Read more … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2015-10-15 10.0 1.0 10.0
Data provided for free by IEX